NCT07437911

A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Athletic Greens International · Industry
• Sex: All
• Age: 18 Years – 59 Years
• Healthy volunteers: Not accepted

Summary

This study is a triple-blind, placebo-controlled, randomized controlled trial of 120 adults that will evaluate the impact of a novel nutritional supplement on improving nutrient gaps and changing nutrient status and the gut microbiome among glucagon-like peptide-1 receptor agonist (GLP-1 RA) users.

Conditions

• Nutrition Intake
• Nutrition Status
• Gastrointestinal Microbiome
• GLP-1

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	AG1 - Nutritional Supplement	AG1 - Nutritional Supplement
DIETARY_SUPPLEMENT	Placebo	Maltodextrin Placebo

Timeline

• Start date: 2026-02-01
• Primary completion: 2026-08-01
• Completion: 2026-08-01
• First posted: 2026-02-27
• Last updated: 2026-02-27

Locations

1 site across 1 country: United States